Weiner David B.
SEC insider (Form 3/4/5 filer). CIK 0001669080. Director at INOVIO PHARMACEUTICALS, INC. (INO). 6 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in PLYMOUTH MEETING, PA.
Companies Weiner David B. has filed insider reports for
- INOVIO PHARMACEUTICALS, INC. (INO): Director
Weiner David B.
CIK: 0001669080
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INOVIO PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
AwardDirectCommon Stock Options
41.8K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
34.2K shares- - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
ExerciseDirect972 shares- - May 21, 2025INO
INOVIO PHARMACEUTICALS, INC.
ExerciseDirect2.2K shares- - Feb 26, 2025INO
INOVIO PHARMACEUTICALS, INC.
ExerciseDirect972 shares- - Feb 26, 2025INO
INOVIO PHARMACEUTICALS, INC.
ExerciseDirect972 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award Common Stock Options | 41,800 | - | - | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 34,200 | - | - | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise | 972 | - | $0 | Direct |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise | 2,167 | - | - | Direct |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise | 972 | - | - | Direct |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise | 972 | - | - | Direct |
1-6 of 6 transactions